A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barry Make, MD, FCCP, FACVPR
National Jewish Health, Denver, United States
Principal InvestigatorKOL profile → - Naimish Patel, MD, PhD
AstraZeneca R&D Boston
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Buenos Aires, Argentina
- Research Site
CABA, Argentina
- Research Site
Ciudad Autónoma de Bs. As., Argentina
- Research Site
Quilmes, Argentina
- Research Site
San Miguel de Tucumán, Argentina
- Research Site
Santiago, Chile
- Research Site
Santiago, Chile
- Research Site
Talca, Chile
- Research Site
Talcahuano, Chile
- Research Site
Assen, Netherlands
- Research Site
Heerlen, Netherlands
- Research Site
Nijmegen, Netherlands
- Research Site
Zutphen, Netherlands
- Research Site
Lima, Peru
- Research Site
Lima, Peru
- Research Site
Cape Town, South Africa
- Research Site
Johannesburg, South Africa
- Research Site
Johannesburg, South Africa
- Research Site
Mount Edgecombe, South Africa
- Research Site
Parktown West, South Africa
- Research Site
eManzimtoti, South Africa
- Research Site
Los Angeles, California, United States
- Research Site
Torrance, California, United States
- Research Site
Denver, Colorado, United States
- Research Site
Hialeah, Florida, United States
- Research Site
Miami, Florida, United States
- Research Site
Pembroke Pines, Florida, United States
- Research Site
Atlanta, Georgia, United States
- Research Site
Blue Ridge, Georgia, United States
- Research Site
Baltimore, Maryland, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Larchmont, New York, United States
- Research Site
Charlotte, North Carolina, United States
- Research Site
Wilmington, North Carolina, United States
- Research Site
Akron, Ohio, United States
- Research Site
Dayton, Ohio, United States
- Research Site
Erie, Pennsylvania, United States
- Research Site
Gaffney, South Carolina, United States
- Research Site
Greenville, South Carolina, United States
- Research Site
Rock Hill, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Oct 2014
- Primary completion
- 4 Apr 2016
- Completion
- 4 Apr 2016
- Last update posted
- 24 May 2018
- Registered enrollment
- 213
- Registry id
- NCT02238483
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.